Stage IV Colorectal Cancer Completed Phase 1 / 2 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0042053 (Stage IV Colorectal Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00784446First-line Therapy of Stage IV Colorectal CancerTreatment